We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Friday, 29 May 2020, highlighting Roche data accepted for presentation via the ASCO20 Virtual Scientific Program May 29-31 2020. 17:00 – 18:15 CEST / 16:00 - 17:15 BST 11:00 – 12:15 am EDT / 8:00 - 9:15 am PDT Audio webcast and conference call will start with a presentation, followed by a Q&A session (live access to the speakers). Access to audio webcast and conference call Dial in details will soon follow. A replay of the webcast will be available via > ir.roche.com

 

Best regards, Karl Mahler Head of Investor Relations	Sabine Borngräber Investor Relations Officer
Roche Investor Relations
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com	Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com
Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com	Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com	Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com	Dr. Lisa Tuomi Phone: +1 650 467 8737 e-mail: tuomi.lisa@gene.com

 

get the latest news and updates to your inbox.